Comparison between the Cobas Integra immunoassay and high-performance liquid chromatography for therapeutic monitoring of carbamazepine

Clinical Biochemistry

Volumn 35, Issue 3, 2002, Pages 251-254

  Hermida, Jesús ^a   Dolores Boveda M ^a   Javier Vadillo, F ^a   Carlos Tutor, J ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ACCURACY; ADOLESCENT; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DRUG BLOOD LEVEL; DRUG DETERMINATION; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEADY STATE; VALIDATION PROCESS; BLOOD; COMPARATIVE STUDY; DRUG MONITORING; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036017163     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00299-0     Document Type: Article

References (24)

1. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update
2. Carbamazepine metabolism in humans: Effect of concurrent anticonvulsant therapy
3. Carbamazepine-10,11-epoxide in therapeutic drug monitoring
4. Mechanisms of action of antiepileptic drugs
5. Characterization of cross reactivity by carbamazepine-10,11-epoxide with carbamazepine assays
6. Therapeutic drug monitoring on Cobas Integra 400. Evaluation results
7. Therapeutic drug monitoring in the Cobas Integra 400 analyzer
8. Plasma enzyme changes and their interpretation in patients receiving anticonvulsants and enzyme inducing drugs
9. The effect of storage conditions on the stability of carbamazepine and carbamazepine-10,11-epoxide in plasma
10. Proposed goals for analytical precision and accuracy in single-point diagnostic testing
11. The determination of calcium, urea and uric acid using the Kodak Ektachem multilayer technology: An evaluation
12. Reference information for the clinical laboratory
13. Improved therapeutic monitoring of drug interactions in epileptic children using carbamazepine polytherapy
14. Plasma clearance of lamotrigine in monotherapy and polytherapy with other antiepileptic drugs
15. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy
16. Pharmacokinetics of lamotrigine
17. Lamotrigine clinical pharmacokinetics
18. Carbamazepine. Therapeutic use and serum concentrations monitoring
19. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy
20. Carbamazepine and its epoxide: Relation of plasma levels to toxicity and seizure control
21. Carbamazepine and its epoxide: An open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy
22. The effect of clobazam on steady state concentrations of carbamazepine and its metabolites
23. Relationship between changes in drug score, D-glucaric acid excretion, and γ-glutamyltransferase and β-glucuronidase serum activities during anticonvulsant treatment
24. Standards of laboratory practice: Antiepileptic drug monitoring